NDC 71506-048

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC: 71506-048
Product root: 71506-048
Identity scope: Product
Primary current NDC product row: Not present

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
compounder	package	71506-048	71506-048-59	COMPOUNDER	Outsourcing facility compounded drug report	2026-1	2026-09-18
compounder	package	71506-048	71506-048-59	COMPOUNDER	Outsourcing facility compounded drug report	2026-1	2026-10-06

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
Establishment	FEI	Product NDC	Package NDC	Product	Active ingredients	Reporting period	Normalization
Fresenius Kabi Compounding LLC DBA Fagron Sterile Services		71506-048	71506-048-59	Vancomycin Hydrochloride	1.75 g/500 mL	2026-1	valid
Fresenius Kabi Compounding LLC DBA Fagron Sterile Services	080570297	71506-048	71506-048-59	Vancomycin Hydrochloride	1.75 g/500 mL	2026-1	valid

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.